Discovery of Promising USP21 Small Molecule Inhibitors: A Computational and Artificial Intelligence Modeling-Based Drug Repurposing Study for Non-Small Cell Lung Cancer.

Kanan T, Kanan D, Kandula M

Open source

DOI
10.1097/coc.0000000000001391
Published
2026 Oct 30
Container
American journal of clinical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/coc.0000000000001391,
  title = {Discovery of Promising USP21 Small Molecule Inhibitors: A Computational and Artificial Intelligence Modeling-Based Drug Repurposing Study for Non-Small Cell Lung Cancer.},
  author = {Kanan T and Kanan D and Kandula M},
  year = {2026},
  journal = {American journal of clinical oncology},
  doi = {10.1097/coc.0000000000001391},
  url = {https://doi.org/10.1097/coc.0000000000001391}
}

RIS

TY  - JOUR
TI  - Discovery of Promising USP21 Small Molecule Inhibitors: A Computational and Artificial Intelligence Modeling-Based Drug Repurposing Study for Non-Small Cell Lung Cancer.
AU  - Kanan T
AU  - Kanan D
AU  - Kandula M
PY  - 2026
JO  - American journal of clinical oncology
DO  - 10.1097/coc.0000000000001391
UR  - https://doi.org/10.1097/coc.0000000000001391
ER  - 

APA

T, K., D, K., & M, K. (2026). Discovery of Promising USP21 Small Molecule Inhibitors: A Computational and Artificial Intelligence Modeling-Based Drug Repurposing Study for Non-Small Cell Lung Cancer.. American journal of clinical oncology. https://doi.org/10.1097/coc.0000000000001391

Source records